Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Riesen

Showing results (131-140 of 133) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 133 results.
Clinical Pharmacology and Therapeutics|May 7, 2010
Role of RAS inhibition in the regulation of Cu/Zn-SOD in the cardiac and peripheral arterial beds in humansG M Kuster, F Nietlispach, W Kiowski, et al.
Clinical Chemistry and Laboratory Medicine|March 22, 2000
A new liquid homogeneous assay for HDL cholesterol determination evaluated in seven laboratories in Europe and the United StatesM Nauck, M S Graziani, J Jarausch, et al.
Der Internist|April 29, 2014
[New AHA and ACC guidelines on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk : Statement of the D•A•CH Society for Prevention of Cardiovascular Diseases, the Austrian Atherosclerosis Society and the Working Group on Lipids and Atherosclerosis (AGLA) of the Swiss Society for Cardiology]G Klose, F U Beil, H Dieplinger, et al.
Pageof 14

Showing results (131-140 of 133) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 133 results.
Clinical Pharmacology and Therapeutics|May 7, 2010
Role of RAS inhibition in the regulation of Cu/Zn-SOD in the cardiac and peripheral arterial beds in humansG M Kuster, F Nietlispach, W Kiowski, et al.
Clinical Chemistry and Laboratory Medicine|March 22, 2000
A new liquid homogeneous assay for HDL cholesterol determination evaluated in seven laboratories in Europe and the United StatesM Nauck, M S Graziani, J Jarausch, et al.
Der Internist|April 29, 2014
[New AHA and ACC guidelines on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk : Statement of the D•A•CH Society for Prevention of Cardiovascular Diseases, the Austrian Atherosclerosis Society and the Working Group on Lipids and Atherosclerosis (AGLA) of the Swiss Society for Cardiology]G Klose, F U Beil, H Dieplinger, et al.
Pageof 14